Amarin Corp Plc (AMRN)

[ggwpq]

If the following statement from the FDA is true,

"Therapy in the high TG groups alone for ACCORD-Lipid and AIM-HIGH did not demonstrate benefit.

DMEP compared those subjects with TG =300 mg/dL to those with TG < 300 mg/dL, …Event rates are similar among subjects with baseline TG=300 mg/dL and TG<300 mg/dL. … "

I'll have to take a few percentage point off of the 53% Jelis rate from R-IT event reduction rate. Anybody disagree?